Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFBA |
Texto Completo: | http://repositorio.ufba.br/ri/handle/ri/15049 |
Resumo: | Texto completo: acesso restrito. p. 543-549 |
id |
UFBA-2_3f8a6e8372a3520ccbce649a86e40f9b |
---|---|
oai_identifier_str |
oai:repositorio.ufba.br:ri/15049 |
network_acronym_str |
UFBA-2 |
network_name_str |
Repositório Institucional da UFBA |
repository_id_str |
1932 |
spelling |
Maia Junior, HugoHaddad, ClaricePinheiro, NathanaelCasoy, JulioMaia Junior, HugoHaddad, ClaricePinheiro, NathanaelCasoy, Julio2014-06-04T16:40:03Z20121179-1411http://repositorio.ufba.br/ri/handle/ri/15049v. 4, n. 1Texto completo: acesso restrito. p. 543-549Background: The effect of resveratrol on the management of endometriosis-related pain was investigated in 12 patients who failed to obtain pain relief during use of an oral contraceptive containing drospirenone + ethinylestradiol. Methods and results: The addition of 30 mg of resveratrol to the contraceptive regimen resulted in a significant reduction in pain scores, with 82% of patients reporting complete resolution of dysmenorrhea and pelvic pain after 2 months of use. In a separate experiment, aromatase and cyclo-oxygenase-2 expression were investigated in the endometrial tissue of 42 patients submitted to laparoscopy and hysteroscopy for the management of endometriosis. Sixteen of these patients were using oral contraceptives alone prior to hospital admission, while the remaining 26 were using them in combination with resveratrol. Inhibition of both aromatase and cyclo-oxygenase-2 expression was significantly greater in the eutopic endometrium of patients using combined drospirenone + resveratrol therapy compared with the endometrium of patients using oral contraceptives alone. Conclusion: These results suggest that resveratrol potentiates the effect of oral contraceptives in the management of endometriosis-associated dysmenorrhea by further decreasing aromatase and cyclo-oxygenase-2 expression in the endometrium.Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-05-19T17:25:55Z No. of bitstreams: 1 Hugo Maia Jr.pdf: 2321618 bytes, checksum: fe0b7e2c8244ca1693f5e19add690514 (MD5)Approved for entry into archive by Flávia Ferreira (flaviaccf@yahoo.com.br) on 2014-06-04T16:40:03Z (GMT) No. of bitstreams: 1 Hugo Maia Jr.pdf: 2321618 bytes, checksum: fe0b7e2c8244ca1693f5e19add690514 (MD5)Made available in DSpace on 2014-06-04T16:40:03Z (GMT). No. of bitstreams: 1 Hugo Maia Jr.pdf: 2321618 bytes, checksum: fe0b7e2c8244ca1693f5e19add690514 (MD5) Previous issue date: 2012http://dx.doi.org/10.2147/IJWH.S36825reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAResveratrolDrospirenoneEndometriosisDysmenorrheaCyclo-oxygenase-2Contraceptive agentsAromataseAdvantages of the association of resveratrol with oral contraceptives for management of endometriosis-related painInternational Journal of Women's Healthinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10000-01-01info:eu-repo/semantics/openAccessengORIGINALHugo Maia Jr.pdfHugo Maia Jr.pdfapplication/pdf2321618https://repositorio.ufba.br/bitstream/ri/15049/1/Hugo%20Maia%20Jr.pdffe0b7e2c8244ca1693f5e19add690514MD51LICENSElicense.txtlicense.txttext/plain1345https://repositorio.ufba.br/bitstream/ri/15049/2/license.txt0d4b811ef71182510d2015daa7c8a900MD52TEXTHugo Maia Jr.pdf.txtHugo Maia Jr.pdf.txtExtracted texttext/plain27964https://repositorio.ufba.br/bitstream/ri/15049/3/Hugo%20Maia%20Jr.pdf.txtda9f11ed79de8cd1ab5afa87a3dd39dfMD53ri/150492022-07-05 14:03:13.421oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-07-05T17:03:13Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false |
dc.title.pt_BR.fl_str_mv |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
dc.title.alternative.pt_BR.fl_str_mv |
International Journal of Women's Health |
title |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
spellingShingle |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain Maia Junior, Hugo Resveratrol Drospirenone Endometriosis Dysmenorrhea Cyclo-oxygenase-2 Contraceptive agents Aromatase |
title_short |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
title_full |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
title_fullStr |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
title_full_unstemmed |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
title_sort |
Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain |
author |
Maia Junior, Hugo |
author_facet |
Maia Junior, Hugo Haddad, Clarice Pinheiro, Nathanael Casoy, Julio |
author_role |
author |
author2 |
Haddad, Clarice Pinheiro, Nathanael Casoy, Julio |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Maia Junior, Hugo Haddad, Clarice Pinheiro, Nathanael Casoy, Julio Maia Junior, Hugo Haddad, Clarice Pinheiro, Nathanael Casoy, Julio |
dc.subject.por.fl_str_mv |
Resveratrol Drospirenone Endometriosis Dysmenorrhea Cyclo-oxygenase-2 Contraceptive agents Aromatase |
topic |
Resveratrol Drospirenone Endometriosis Dysmenorrhea Cyclo-oxygenase-2 Contraceptive agents Aromatase |
description |
Texto completo: acesso restrito. p. 543-549 |
publishDate |
2012 |
dc.date.issued.fl_str_mv |
2012 |
dc.date.accessioned.fl_str_mv |
2014-06-04T16:40:03Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://repositorio.ufba.br/ri/handle/ri/15049 |
dc.identifier.issn.none.fl_str_mv |
1179-1411 |
dc.identifier.number.pt_BR.fl_str_mv |
v. 4, n. 1 |
identifier_str_mv |
1179-1411 v. 4, n. 1 |
url |
http://repositorio.ufba.br/ri/handle/ri/15049 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.pt_BR.fl_str_mv |
http://dx.doi.org/10.2147/IJWH.S36825 |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFBA instname:Universidade Federal da Bahia (UFBA) instacron:UFBA |
instname_str |
Universidade Federal da Bahia (UFBA) |
instacron_str |
UFBA |
institution |
UFBA |
reponame_str |
Repositório Institucional da UFBA |
collection |
Repositório Institucional da UFBA |
bitstream.url.fl_str_mv |
https://repositorio.ufba.br/bitstream/ri/15049/1/Hugo%20Maia%20Jr.pdf https://repositorio.ufba.br/bitstream/ri/15049/2/license.txt https://repositorio.ufba.br/bitstream/ri/15049/3/Hugo%20Maia%20Jr.pdf.txt |
bitstream.checksum.fl_str_mv |
fe0b7e2c8244ca1693f5e19add690514 0d4b811ef71182510d2015daa7c8a900 da9f11ed79de8cd1ab5afa87a3dd39df |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA) |
repository.mail.fl_str_mv |
|
_version_ |
1808459478641672192 |